What do these data mean with respect to fulfilling the mission of Epilepsia as an international journal and having a paper accepted by individual country? Epilepsia is fulfilling its mission by publishing high quality papers from around the world. Many published papers are from the United States; however, this is also the country with the highest number of submissions, so it should not be a surprise. Other countries also have higher acceptance rates. Hence, Epilepsia does not appear to discriminate in accepting papers by country.
As is true for journals with higher impact factors, Epilepsia makes acceptance decisions according to the quality and impact of submissions. As presented by Phil Schwartzkroin, immediate past Editor-in-Chief of Epilepsia in the accompanying letter from Dr. Hu and colleagues, those qualities include submissions that focus on important and interesting topics; have clearly stated goals and objectives; the observations and findings are novel and change the way we think about epilepsy; and the study is well designed and includes adequate sample size, comparison groups, and statistical analyses. It is also important that the data are appropriately interpreted and not overly construed.
We hope this addresses the question about publication by country for Epilepsia. The Journal is committed to publishing the best quality and high impact research related to epilepsy, especially of international importance. As Editors, we encourage authors, especially new investigators, to consider submitting your work to Epilepsia. We promise to give your work a fair review without bias to geography, but with a bias toward quality and impact.
We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.
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